<DOC>
	<DOCNO>NCT02173119</DOCNO>
	<brief_summary>Transcatheter arterial chemoembolization ( TACE ) widely accept palliative therapy treatment HCC . Palliative mean cure disease prolongs life improve quality life . During TACE , mixture chemotherapy drug combine oil call lipiodol . Lipiodol role drug carrier embolic agent ( material block blood flow tumor ) . The lipiodol/chemotherapy mixture inject artery ( blood vessel ) directly supply blood HCC tumor . Lipiodol make fat water see MRI . Therefore , MRI use quantify amount lipiodol deliver HCC tumor . In study , investigator want see patient survival related amount lipiodol deliver HCC tumor .</brief_summary>
	<brief_title>Can Quantitative MRI After cTACE Help Predict Survival ?</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Ethiodized Oil</mesh_term>
	<criteria>Prospective study perform 20 patient Hepatocellular Carcinoma ( HCC ) independently schedule undergo TACE ; tumor candidate already deem unresectable . Reasons may include concurrent comorbidities include cardiac respiratory compromise recurrent multilobar disease cirrhosis portal hypertension vascular invasion high tumor burden contraindication general anesthesia . Diagnosis HCC establish ) biopsy b ) noninvasively , base upon &gt; 2cm diameter tumor characteristic imaging finding set cirrhosis . Male female age 18 89 year , ethnicity Infiltrative diffuse HCC . Does meet inclusion criterion . Pregnant woman . Individuals pacemaker nonMRI compatible metallic implant . Hemodialysis patient patient severely impaired renal function . Individuals severe claustrophobia unwilling get MRI .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hepatocellular</keyword>
	<keyword>Carcinoma</keyword>
	<keyword>HCC</keyword>
	<keyword>lipiodol</keyword>
</DOC>